Today's Reaction to GE Will Tell Us a Lot<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />4/11/2008 8:55 AM EDT<br /><br />I have never been lost, but I will admit to being confused for several weeks. <br />-- Daniel Boone<br /> <br /> <br />The bad news is that General Electric's (GE) poor earnings report this morning is confusing already muddled market. The good news is that this is going to be a good test of how the market is going to deal with what is likely to be a very difficult earnings season. <br /><br />Since the start of the second quarter, the market action has been the best of the year. We have had some rallies, some pockets of momentum and have held above key technical levels. However, there continues to be a heavy level of caution, and the tepid volume is a clear indication of the failure to truly embrace the idea that things are getting better. <br /><br />Although the market has done a good job of holding up on poor news like the monthly jobs reports and the minutes of the Fed meeting, it has not had any good news to really get things moving. Not going down on bad news is a good sign, but if good news isn't eventually forthcoming, the selling pressure will eventually build up and we will start to drift down. <br /><br />The poor GE earnings report and higher-than-expected import prices this morning are going to tell us if this market is healthy enough to handle bad news. The GE report is obviously coming as a surprise to the market, but it really shouldn't be a surprise that the weakness is due to financial services. The market has been struggling to price in issues in the financial sector for many months now, and this reaction to GE will tell us whether the market is now concerned that another barrage of bad news is likely to hit. <br /><br />Technically the market is still in pretty good shape. The key level is the gap up open on April 1. The action yesterday helped the technical picture yesterday, but the lack of volume the last few weeks makes it hard to have any real conviction. <br /><br />The market is muddled and confused, but some positives are starting to pop up. The reaction to GE today is going to tell us a lot about where things are headed as we start earnings season. If the market can shrug off GE, it bodes very well for the bulls, but confidence out there is shaky and it isn't going to be easy to get much upside traction going. <br /><br /><br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: CDIC +16.1%, PRLS +11.1%, EXAC +5.8%, PZN +5.1%, FAST +4.0%, SJR +2.8%, BSET +2.1%, CTCT +1.3%, IRIX +1.1%... M&A news: TZIX +18.8% (to be acquired by Apax Partners for $22/share)... Other news: ADLS +11.7% (announces that, based on a productive meeting with the FDA, it plans to submit a New Drug Application in the third quarter of 2008 for its novel once-a-day oral antibiotic; also upgraded to Buy at Lazard), CVTX +10.8% (CV Therapeutics and Astellas announce FDA approval for Lexiscan injection), PDLI +10.6% (declares a special cash dividend of $4.25 per share; announces plan to separate its biotechnology operations from its antibody humanization royalty assets), BNS +6.9% (WSJ reports NCC draws interest of Bank of Nova Scotia), DAL +6.2% (continued strength following report that Delta-Northwest merger may be announced next week; also upgraded to Outperform at Credit Suisse), CCJ +2.9% (continued speculation that China signals takeover interest), FTE +2.7% (says 'no current plans' for major share buyback - Thomson), NCC +2.1% (draws interest of Bank of Nova Scotia - WSJ), ANGO +1.6% (offers to purchase certain Diomed assets in the United States and United Kingdom; co to pay $11 mln for assets), BHI +1.5% (Cramer makes positive comments on MadMoney), HRB +1.5% (Director Richard Breeden buys 2 mln shares at $21.61-21.89), NWA +1.2% (continued strength following report that Delta-Northwest merger may be announced next week; also upgraded to Outperform at Credit Suisse)... Analyst upgrades: CNTF +2.1% (initiated with Buy at Roth), CLNE +1.3% (initiated with a Buy at Lazard), MHS +1.0% (upgraded to Outperform at Credit Suisse). <br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: DLA -14.3%, PWER -12.7%, ACPW -11.6%, GE -10.2% (also downgraded at tier-1 firm following earnings and downgraded to Neutral at Credit Suisse), FDRY -8.5% (also downgraded to Sell at BWS Financial), STSA -8.0%, INTV -7.8%, ETFC -2.3%, DNA -1.9% (also downgraded to Mkt Weight at Weisel)... Select financial names showing weakness: CIT -6.9%, FMD -5.3%, PMI -4.9%, WB -2.2%, MS -2.1%, BAC -1.5%, WM -1.5% (Bloomberg reports Goldman Sachs cuts their 2008-10 ests for Washington Mutual), GS -1.4%, C -1.3% (Business Week discusses C in the Inside Wall Street section)... Select solar stocks trading lower: AKNS -6.2%, SOLF -3.9%, JASO -3.6%, ESLR -3.5%, SPWR -2.5%, FSLR -1.5%... Other news: FRNT -75.2% (files for Chapter 11), PCOP -11.1% (Leslie Browne resigns as President and Chief Executive Officer), NVT -5.6% (has dialogue with EU over Navteq, Kauppalehti reports - Bloomberg), SNDK -3.8% (Needham expects conservative 2Q08 guidance and lower full year guidance and Barron's Online discusses SNDK in Weekday Trader column), HLF -3.8% ("The Fraud Discovery Institute" is out with a list of the "Top Ten Red Flags of Fraud at Herbalife"), CSG -3.0% (Q1 confectionery underlying sales growth 7% - Forbes), SI -2.9% (German shares drop on General Electric report, led by Siemens - Bloomberg.com), TYC -2.8% (still checking), NVDA -2.3% (still checking), JAVA -2.0% (AGYS announces it has amended the original earn-out agreement payable to former shareholders of Innovativ Systems Design, a Sun Microsystems reseller), PRU -1.0% (designates shelf registration statement and files prospectus supplement to effect resales of its floating rate convertible senior notes due December 15, 2037)... Analyst downgrades: ZRAN -8.6% (downgraded to Underperform at Jefferies), INTV -7.1% (downgraded to Equal Weight from Overweight at First Analysis), IDA -3.8% (downgraded to Underwt at JPMorgan), JCI -3.2% (downgraded to Neutral at JPMorgan), STX -3.1% (downgraded to Neutral at tier 1 firm), GRMN -2.3% (downgraded to Perform at Oppenheimer), ANF -1.9% (downgraded to Neutral at JPMorgan), RRGB -1.5% (downgraded to Mkt Perform at Wachovia), SIRI -1.2% (initiated with Sell at Merrill).